Related references
Note: Only part of the references are listed.Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune disease
Yoshihiko Tomofuji et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry
Koshiro Sonomoto et al.
RHEUMATOLOGY (2022)
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis
Kazuyoshi Ishigaki et al.
NATURE GENETICS (2022)
Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic component
Yuya Shirai et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Distinct transcriptome architectures underlying lupus establishment and exacerbation
Masahiro Nakano et al.
CELL (2022)
Why remission is not enough: underlying disease mechanisms in RA that prevent cure
Georg Schett et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
A cross-population atlas of genetic associations for 220 human phenotypes
Saori Sakaue et al.
NATURE GENETICS (2021)
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases
Mineto Ota et al.
CELL (2021)
Parsing multiomics landscape of activated synovial fibroblasts highlights drug targets linked to genetic risk of rheumatoid arthritis
Haruka Tsuchiya et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis
Ippei Miyagawa et al.
RHEUMATOLOGY (2019)
Lymphocyte phenotype and its application to precision medicine in systemic autoimmune diseases
Yoshiya Tanaka et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
Yoshiya Tanaka et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Genetics of rheumatoid arthritis contributes to biology and drug discovery
Yukinori Okada et al.
NATURE (2014)
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Takao Koike et al.
MODERN RHEUMATOLOGY (2011)
Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study
Y. Tanaka et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
T. Takeuchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): Evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
Norihiro Nishimoto et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody - A multicenter, double-blind, placebo-controlled trial
N Nishimoto et al.
ARTHRITIS AND RHEUMATISM (2004)